108 
National Science Foundation and other relevant Federal 
agencies on helium conservation activities. 
‘‘(d) DURATION.—The program established under this 
section shall receive support for a period of not more than 
5 years, subject to the availability of appropriations. 
‘‘(e) RENEWAL.—Upon expiration of any period of 
support of the program under this section, the Director may 
renew support for the program for a period of not more 
than 5 years. 
‘‘SEC. 315. OFFICE OF SCIENCE EMERGING INFECTIOUS DIS-
EASE COMPUTING RESEARCH INITIATIVE. 
‘‘(a) IN GENERAL.—The Secretary, in coordination 
with the Director of the National Science Foundation and 
the Administrator of the National Aeronautics and Space 
Administration, shall establish within the Office of Science, 
a cross-cutting research initiative to leverage the Federal 
Government’s innovative analytical resources and tools, 
user facilities, and advanced computational and networking 
capabilities in order to prevent, prepare for, and respond 
to emerging infectious diseases, including COVID–19. The 
Secretary shall carry out this initiative through a competi-
tive, merit-reviewed process, and consider applications from 
National Laboratories, institutions of higher education, 
multi-institutional collaborations, industry partners and 
other appropriate entities. 
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00108
Fmt 6652
Sfmt 6203
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS
109 
‘‘(b) ACTIVITIES.—In carrying out the initiative estab-
lished under subsection (a), the Secretary shall coordinate 
with programs across the Office of Science and with rel-
evant Federal agencies to determine a comprehensive set of 
technical milestones for these research activities and 
prioritize the following objectives— 
‘‘(1) supporting fundamental research and devel-
opment in advanced analytics, experimental studies, 
materials 
synthesis, 
high-performance 
computing 
technologies needed to characterize, model, simulate, 
and predict complex phenomena and biological mate-
rials related to emerging infectious diseases, including 
COVID–19 challenges, including a focus on testing 
and diagnostics, experimental data acquisition, shar-
ing and management, advanced manufacturing, and 
molecular design and modeling; 
‘‘(2) using expertise from the private sector, in-
stitutions of higher education, and the National Lab-
oratories to develop computational software and capa-
bilities that prospective users may accelerate emerging 
infectious diseases research and development; 
‘‘(3) leveraging the research infrastructure of the 
Department, including scientific computing user fa-
cilities, x-ray light sources, neutron scattering facili-
ties, nanoscale science research centers, and sequenc-
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00109
Fmt 6652
Sfmt 6203
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS
110 
ing and bio-characterization facilities by coordinating 
with the Advanced Scientific Computing Research, 
Basic Energy Sciences, and Biological and Environ-
mental Research programs within the Office of 
Science; 
‘‘(4) leveraging experience from existing mod-
eling and simulation research and work sponsored by 
the Department and promoting collaboration and 
data sharing between National Laboratories, research 
entities, and user facilities of the Department by pro-
viding the necessary access and secure data transfer 
capabilities; and 
‘‘(5) ensuring that new experimental and com-
putational tools are accessible to relevant research 
communities, including private sector entities to ad-
dress emerging infectious diseases, including COVID– 
19 challenges. 
‘‘(c) COORDINATION.—In carrying out this initiative, 
the Secretary shall ensure, to the maximum extent prac-
ticable, coordination of these activities with the Department 
of Energy National Laboratories, institutions of higher edu-
cation, and the private sector. 
‘‘(d) EMERGING INFECTIOUS DISEASES HIGH PER-
FORMANCE COMPUTING RESEARCH CONSORTIUM.— 
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00110
Fmt 6652
Sfmt 6203
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS
111 
‘‘(1) IN GENERAL.—The Secretary in coordina-
tion with the Director of the National Science Foun-
dation and the Director of the Office of Science and 
Technology Policy shall establish and operate an 
Emerging Infectious Diseases High Performance 
Computing Research Consortium (referred to in this 
section as the ‘Consortium’), in order to support the 
initiative under subsection (a) by providing, to the 
extent practicable, a centralized entity for multidisci-
plinary, collaborative, emerging infectious disease re-
search and development through high performance 
computing and advanced data analytics technologies 
and processes. 
‘‘(2) MEMBERSHIP.—The members of such con-
sortium may include representatives from relevant 
Federal agencies, the private sector, institutions of 
higher education, which can each contribute relevant 
compute time, capabilities, or other resources. 
‘‘(3) ACTIVITIES.—The Consortium shall— 
‘‘(A) match applicants with available Fed-
eral and private sector computing resources; 
‘‘(B) consider supplemental awards for com-
puting partnerships with Consortium members 
to qualifying entities on a competitive merit-re-
view basis; 
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00111
Fmt 6652
Sfmt 6203
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS
112 
‘‘(C) encourage collaboration and commu-
nication among member representatives of the 
consortium and awardees; 
‘‘(D) make available the high-performance 
computing capabilities, expertise, and user fa-
cilities of the Department and the National Lab-
oratories; and 
‘‘(E) submit an annual report to the Sec-
retary summarizing the activities of the Consor-
tium, including— 
‘‘(i) describing each project undertaken 
by the Consortium; 
‘‘(ii) detailing organizational expendi-
tures; and 
‘‘(iii) evaluating contribution to the 
achievement of technical milestones as deter-
mined in subsection (a). 
‘‘(4) COORDINATION.—The Secretary shall ensure 
the coordination of, and avoid unnecessary duplica-
tion of, the activities of the Consortium with the ac-
tivities of other research entities of the Department, 
institutions of higher education and the private sec-
tor. 
‘‘(e) REPORT.—Not later than 2 years after the date 
of enactment of the Department of Energy Science for the 
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00112
Fmt 6652
Sfmt 6203
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS
114 
potential to generate pathogens with high trans-
missibility and high virulence in humans. 
‘‘SEC. 316. AUTHORIZATION OF APPROPRIATIONS. 
‘‘There are authorized to be appropriated to the Sec-
retary to carry out the activities described in this title— 
‘‘(1) $8,801,915,000 for fiscal year 2022; 
‘‘(2) $9,451,015,300 for fiscal year 2023; 
‘‘(3) $10,160,677,621 for fiscal year 2024; 
‘‘(4) $10,693,625,004 for fiscal year 2025; and 
‘‘(5) $11,145,798,345 for fiscal year 2026.’’. 
(b) TABLE OF CONTENTS.—Section 1(b) of the Depart-
ment of Energy Research and Innovation Act is amended 
in the table of contents by inserting after the item relating 
to section 309 the following: 
‘‘Sec. 310. Accelerator research and development. 
‘‘Sec. 311. Isotope Development and Production for Research Applications. 
‘‘Sec. 312. Increased collaboration with teachers and scientists. 
‘‘Sec. 313. High intensity laser research initiative. 
‘‘Sec. 314. Helium conservation program. 
‘‘Sec. 315. Office of Science Emerging Infectious Disease Computing Research 
Initiative. 
‘‘Sec. 316. Authorization of appropriations.’’. 
SEC. 14. STATE-OWNED ENTERPRISES PROHIBITION. 
(a) INNOVATE IN AMERICA.—None of the funds author-
ized or made available by this Act, or the amendments made 
by this Act, may be used in awarding a contract, sub-
contract, grant, or loan to an entity that— 
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00114
Fmt 6652
Sfmt 6203
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS
115 
(1) is owned or controlled by, is a subsidiary of, 
or is otherwise related legally or financially to a cor-
poration based in a country that— 
(A) is identified as a nonmarket economy 
country (as defined in section 771(18) of the 
Tariff Act of 1930 (19 U.S.C. 1677(18))) as of 
the date of enactment of this Act; 
(B) was identified by the United States 
Trade Representative in the most recent report 
required by section 182 of the Trade Act of 1974 
(19 U.S.C. 2242) as a priority foreign country 
under subsection (a)(2) of that section; and 
(C) is subject to monitoring by the Trade 
Representative under section 306 of the Trade 
Act of 1974 (19 U.S.C. 2416); or 
(2) is listed pursuant to section 9(b)(3) of the 
Uyghur Human Rights Policy Act of 2020 (Public 
Law 116–145). 
(b) EXCEPTION.—For purposes of subsection (a), the 
Secretary may issue a waiver, to be made publicly avail-
able, to an entity in which the legal or financial connection 
to a corporation is a minority relationship or investment. 
(c) INTERNATIONAL AGREEMENTS.—This section shall 
be applied in a manner consistent with the obligations of 
the United States under international agreements. 
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00115
Fmt 6652
Sfmt 6203
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS
Union Calendar No. 50 
117TH CONGRESS 
1ST SESSION 
H. R. 3593 
[Report No. 117–72] 
A BILL 
To provide guidance for and investment in the re-
search and development activities of the Depart-
ment of Energy Office of Science, and for other 
purposes. 
JUNE 28, 2021 
Reported with an amendment, committed to the Com-
mittee of the Whole House on the State of the Union, 
and ordered to be printed 
VerDate Sep 11 2014 
00:46 Jun 29, 2021
Jkt 019200
PO 00000
Frm 00116
Fmt 6651
Sfmt 6651
E:\BILLS\H3593.RH
H3593
pamtmann on DSKBC07HB2PROD with BILLS